Gastroenterology Clinical Trials
The gastroenterology team at Doylestown Health participates in clinical trials and research to help shape the way gastrointestinal disease is treated.
Active Trials - Open to Enrollment:
Non-alcoholic Stearotic Hepatitis (NASH, fatty liver) - REGENERATE (NASH)
- Evaluating the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
- Coordinated by the Doylestown Health Medical Research Department: 215-345-2119
Active Trials - Not Accepting New Patients:
Moderate to severe Ulcerative Colitis - UNIFI
- Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis
- Enrolled patients in follow up through February 2020
For more information about Doylestown Health's open trials visit the U.S. National Institutes of Health's Clinical Trials database.